Proposed definitions of T cell-mediated rejection and tubulointerstitial inflammation as clinical trial endpoints in kidney transplantation (Transplant International, 2022)

(untitled) - Seron, D; Rabant, M; Becker, JU; Roufosse, C; Bellini, MI; Böhmig, GA; Budde, K; Diekmann, F; Glotz, D; Hilbrands, L; Loupy, A; Oberbauer, R; et al.